CD4 and sarcoidosis: The major strength of this study is that sarcoidosis cases in both LS and non-LS and healthy controls are well-characterized and that we were able to inspect genetic variants associated with CD3+, CD4+, and CD8+ T-cell levels and CD4/CD8 ratio in the genetics of LS and non-LS (as tagged by the Immunochip SNP-array).